A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
New AI algorithms could help detect prostate cancer more efficiently, according to a doctor with Cleveland Clinic.
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.
A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
Morning Overview on MSN
New prostate cancer immunotherapy cuts biomarkers by up to 99% in trial
A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...
But as it turned out, his transition from military service to civilian life came with prostate cancer. It was during his ...
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results